Triple

T18213096
Position Surface form Disambiguated ID Type / Status
Subject Lugano classification E436081 entity
Predicate endorsedBy P18857 FINISHED
Object International Conference on Malignant Lymphoma NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: International Conference on Malignant Lymphoma | Statement: [Lugano classification, endorsedBy, International Conference on Malignant Lymphoma]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: International Conference on Malignant Lymphoma
Context triple: [Lugano classification, endorsedBy, International Conference on Malignant Lymphoma]
  • A. Leukemia and Lymphoma Research
    Leukemia and Lymphoma Research is a UK-based medical research charity dedicated to improving the diagnosis, treatment, and prevention of blood cancers such as leukemia and lymphoma.
  • B. Hodgkin
    Hodgkin is a surname most famously associated with Dorothy Hodgkin, the Nobel Prize–winning British chemist who advanced the field of X-ray crystallography.
  • C. Hodgkin lymphoma
    Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, characterized by the presence of abnormal Reed–Sternberg cells and often affecting lymph nodes.
  • D. non-Hodgkin lymphoma
    Non-Hodgkin lymphoma is a diverse group of blood cancers that originate in the lymphatic system from abnormal lymphocytes and can vary widely in aggressiveness and prognosis.
  • E. American Society of Hematology
    The American Society of Hematology is a leading professional organization dedicated to advancing the understanding, diagnosis, treatment, and prevention of blood-related diseases through research, education, and advocacy.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: International Conference on Malignant Lymphoma
Target entity description: The International Conference on Malignant Lymphoma is a major global scientific meeting that brings together experts to present and discuss advances in the research, diagnosis, and treatment of lymphoid cancers.
  • A. Leukemia and Lymphoma Research
    Leukemia and Lymphoma Research is a UK-based medical research charity dedicated to improving the diagnosis, treatment, and prevention of blood cancers such as leukemia and lymphoma.
  • B. Hodgkin
    Hodgkin is a surname most famously associated with Dorothy Hodgkin, the Nobel Prize–winning British chemist who advanced the field of X-ray crystallography.
  • C. Hodgkin lymphoma
    Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, characterized by the presence of abnormal Reed–Sternberg cells and often affecting lymph nodes.
  • D. non-Hodgkin lymphoma
    Non-Hodgkin lymphoma is a diverse group of blood cancers that originate in the lymphatic system from abnormal lymphocytes and can vary widely in aggressiveness and prognosis.
  • E. American Society of Hematology
    The American Society of Hematology is a leading professional organization dedicated to advancing the understanding, diagnosis, treatment, and prevention of blood-related diseases through research, education, and advocacy.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8b90dba6481908e119eb9aa4ca0cb completed April 10, 2026, 8:47 a.m.
NER Named-entity recognition batch_69e4e22a26308190a6720b41a9bbfc2d completed April 19, 2026, 2:09 p.m.
Created at: April 10, 2026, 10:32 a.m.